Takeda Execs Admitted To Actos Scheme, Relator Claims
A former GlaxoSmithKline executive turned whistleblower told a Massachusetts federal court Monday that Takeda Pharmaceutical executives admitted to a kickback scheme for the diabetes drug Actos and that acknowledgement overrides Takeda's...To view the full article, register now.
Already a subscriber? Click here to view full article